阿里巴巴(9988.HK)上市第二日高開1.28%
格隆匯11月27日丨隔夜阿里巴巴(BABA.US)漲2.29%報194.82美元,續刷近半年來新高,1拆8摺合成港股價格為190.64港元/股。阿里巴巴(9988.HK)繼昨日首日上市漲6.59%後,今日高開1.28%,開報190港元,盤前成交3.3億港元,最新總市值4.06萬億港元。 據悉,若考慮悉數行使超額配股權,阿里巴巴此次最高募集資金1012億港元(約合130億美元)。即使不行使超額配股權,也超過融資81億美元的Uber,為2019年以來全球規模最大的新股發行,同時也是2011年以來香港融資規模最大的公開發行。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.